Rifampin and rifabutin resistance mechanism in Helicobacter pylori

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 6, 1999, Pages 1497-1499

  Heep, Markus ^a   Beck, Daniela ^a   Bayerdörffer, Ekkehard ^b   Lehn, Norbert ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; METRONIDAZOLE; RIFABUTIN; RIFAMPICIN; RIFAMYCIN;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BACTERIUM MUTANT; CONTROLLED STUDY; ESCHERICHIA COLI; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY;

EID: 0033001534     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.6.1497     Document Type: Article

References (13)

1. Abadi, F. J. R., P. E. Carter, P. Cash, and T. H. Pennington. 1996. Rifampin resistance in Neisseria meningitidis due to alterations in membrane permeability. Antimicrob. Agents Chemother. 40:646-651.
2. Blanc-Potard, A. B., E. Gari, F. Spirito, N. Figueroa-Bossi, and L. Bossi. 1995. RNA polymerase (rpoB) mutants selected for increased resistance to gyrase inhibitors in Salmonella typhimurium. Mol. Gen. Genet. 247:680-692.
3. Enright, M., P. Zawadski, P. Pickerill, and C. G. Dowson. 1998. Molecular evolution of rifampicin resistance in Streptococcus pneumoniae. Microb. Drug Resist. 4:65-70.
4. Kunin, C. M. 1996. Antimicrobial activity of rifabutin. Clin. Infect. Dis. 22(Suppl. 1):S3-S13.
5. National Committee for Clinical Laboratory Standards. 1997. Approved standard M7-A4. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. National Committee for Clinical Laboratory Standards, Wayne, Pa.
6. Nolte, O. 1997. Rifampicin resistance in Neisseria meningitidis: evidence from a study of sibling strains, description of new mutations and notes on population genetics. J. Antimicrob. Chemother. 39:747-755.
7. Ohno, H., H. Koga, S. Kohno, T. Tashiro, and K. Hara. 1996. Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Antimicrob. Agents Chemother. 40:1053-1056.
8. Perri, F., V. Festa, and A. Andriulli. 1998. Treatment of antibiotic-resistant Helicobacter pylori infection. N. Engl. J. Med. 339:53.
9. Severinov, K., M. Soushko, A. Goldfarb, and V. Nikiforov. 1993. Rifampicin region revisited. New rifampicin-resistant and streplolydigin-resistant mutants in the beta subunit of Escherichia coli RNA polymerase. J. Biol. Chem. 268:14820-14825.
10. Tomb, J. F., O. White, A. R. Kerlavage, R. A. Clayton, G. G. Sutton, R. D. Fleischmann, K. A. Ketchum, H. P. Klenk, S. Gill, B. A. Dougherty, K. Nelson, J. Quackenbush, L. Zhou, E. F. Kirkness, S. Peterson, B. Loftus, D. Richardson, R. Dodson, H. G. Khalak, A. Glodek, K. McKenney, L. M. Fitzegerald, N. Lee, M. D. Adams, and J. C. Venter. 1997. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388: 539-547.
11. Troyer, J. M., S. Radulovic, S. G. E. Andersson, and A. F. Azad. 1998. Detection of point mutations in rpoB gene of rifampin-resistant Rickettsia typhi. Antimicrob. Agents Chemother. 42:1845-1846.
12. Williams, D. L., L. Spring, L. Collins, L. P. Miller, L. B. Heifets, P. R. J. Gangadharam, and T. P. Gillis. 1998. Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 42:1853-1857.
13. Yee, Y. C., B. Kisslinger, V. L. Yu, and D. J. Jin. 1996. A mechanism of rifamycin inhibition and resistance in Pseudomonas aeruginosa. J. Antimicrob. Chemother. 38:133-137.